
A clinical trial found that a single dose of subcutaneous (sc) furosemide significantly improved diuretic efficiency and peak urine sodium compared to oral furosemide in heart failure (HF) patients with diuretic resistance (DR) following hospitalization. In 70 participants, those with DR showed better outcomes with sc furosemide (34.0 ml/mg diuretic efficiency and 100 mmol/L peak urine sodium) compared to oral furosemide (22.6 ml/mg and 83 mmol/L, respectively). No significant difference was found in participants without DR. The study suggests sc furosemide as a promising option for improving treatment outcomes in HF patients with DR.
Like
Save
Share